News | Cath Lab | August 22, 2016

DMC Heart Hospital Completes Complex High-Risk Indicated Interventional Procedure Course

Veteran interventional cardiologists and DMC Heart Hospital leadership offered four clinically complex PCI cases via live feed during the course

DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training

August 22, 2016 — The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course, utilizing an unprecedented four live, clinically complex cases. Participating physicians included: DMC Heart Hospital President Theodore Schreiber, M.D.; Vice President Cindy Grines, M.D.,; Medical Director of the Cardiac Care Unit and Chief of Cardiology Mahir Elder, M.D.; Cardiac Catheterization Lab Medical Director Amir Kaki, M.D.; and Tamam Mohamad, M.D.

The Complete Revascularization of Higher Risk Patients (frequently abbreviated as “CHIP”) program is geared toward the interventionalist seeking to better understand complex percutaneous coronary intervention (PCI) in the modern era. Presentations address treatment of left main disease, chronic total occlusions, long lesions, bifurcation lesions, “small vessels” and saphenous vein grafts. In addition, participants learn how to manage challenging patient subsets, such as those with advanced heart failure, as well as how to provide optimal hemodynamic support.

The course is a combination of live complex cases, hands-on workstations and didactic. DMC provided four live complex cases; traditionally, most accounts only do one or two live cases. The cases are displayed via live video feed from the cardiac catheterization lab to the education room.

This course educated interventional physicians on an option for patients that are too sick for surgery or refuse surgery. By training other interventional cardiologists on why, how and which patients are U.S. Food and Drug Administration (FDA)-indicated for supported PCI, more heart failure patients can be treated effectively, versus being sent home on medical management. Additionally, the data shows when treated by supported PCI, these patients stay in the hospital for a shorter periods of time, they feel better once they leave and they experience less readmissions.

“No other Complex PCI CHIP course has ever demonstrated four live cases as complex as the ones showcased on Monday,” according to Schreiber. “However, it is not only the case complexity and the positive outcomes achieved, but the ability to engage the audience with questions, knowledge, charm and even some humor, which makes this course an impactful and memorable experience for all.”

For more information: www.dmc.org


Related Content

News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
Subscribe Now